Liver News and Research

RSS

Despite spending more for health care, Americans do not have the best medical care in the world

Despite spending more for health care, Americans do not have the best medical care in the world, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions.

6 May 2004

A second-generation targetted antibody for potential cancer therapy

The overproduction, or 'overexpression', of the epidermal growth factor receptor (EGFR) is one of the most common aberrations in cancer, and subsequently agents that inhibit EGFR are among the most hotly-pursued potential products in the pharmaceutical industry.

6 May 2004

New guidelines for using new antiepileptic drugs to treat epilepsy

The number of drugs available to treat epilepsy have more than doubled in the last decade. The American Academy of Neurology and the American Epilepsy Society have assembled the top experts in the field to evaluate the available data of 1,462 research articles in order to create a guideline for the treatment of epilepsy with the new antiepileptic drugs (AEDs).

6 May 2004

Embryo testing could produce babies who might aid sick siblings

Parents with a child requiring stem cell transplantation can have genetic testing done on embryos prior to implantation to determine if the tissue type matches and the ensuing offspring could potentially serve as a donor to the affected child, according to a study in the May 5 issue of The Journal of the American Medical Association (JAMA).

5 May 2004

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Progen Industries Limited, an Australian anti-cancer drug development company, announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for their lead anti-angiogenesis product PI-88 for treatment of malignant melanoma.

3 May 2004

Study suggests that the vitamins, such as E, C, and beta carotene, could raise bad form of cholesterol

The notion that antioxidant vitamins could provide a safe, convenient way to protect the heart from disease appears to have hit a pothole.

3 May 2004

Study identifies key factor causing low iron and anemia in patients with infections and major inflammatory diseases

UCLA researchers found that a member of the immune system’s defense team stimulates a chain reaction leading to chronic anemia in many patients with infections and major inflammatory diseases.

3 May 2004

Wyeth gets FDA approval for a novel protein device that enhances bone healing

Wyeth have announced that the FDA has approved rhBMP-2/ACS (recombinant human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge), a novel protein device that enhances bone healing, for use in the treatment of acute, open tibia shaft fractures in adults.

3 May 2004

New radiology camera delivers sophisticated technology to Cambridge Medical Center patients

When most of us think of new cameras, we think about those little digital pocket-sized ones that easily fit into the palm of our hand. It’s amazing how much technology is contained in something so small.

3 May 2004

Study of an oral fumarate shows improvement in psoriasis

Biogen Idec and Fumapharm AG today announced results from a Phase II study of BG-12, an oral fumarate, in patients with severe psoriasis.

29 Apr 2004

Shubao slimming capsules contain illegal Fenfluramine and Nitrosofenfluramine

Following a report of a UK case of liver failure suspected to be associated with an unlicensed traditional Chinese medicine (TCM), the MHRA has discovered the illegal and dangerous inclusion of nitrosofenfluramine and fenfluramine, in Shubao Slimming Capsules being supplied on the UK market.

28 Apr 2004

California has set a public health goal for arsenic levels in drinking water

The California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA) today announced the publication of a final Public Health Goal (PHG) for arsenic in drinking water.

27 Apr 2004

NYU School of Medicine and Bellevue to examine health issues in hispanic population

Renowned Latino leaders in the health and political community will gather at a free two-day conference to discuss issues affecting the community at “Latino Health: Progress through Action”.

27 Apr 2004

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.

26 Apr 2004

Research yields new epilepsy guidelines

In conjunction with the AMA, the American Academy of Neurology and the American Epilepsy Society on April 26 jointly announced new guidelines for treating epilepsy. The number of anti-epileptic drugs has more than doubled in the last decade.

26 Apr 2004

First pancreatic islet cell transplant in Alabama

A lifelong dependency on insulin shots and pumps may be over for a 24-year old Troy, Alabama, woman who is the first in the state to receive a pancreatic islet cell transplant. Within 24 hours after the procedure, performed at UAB Hospital on April 15, her new cells were beginning to function, doctors said.

24 Apr 2004

Scientists have developed a better form of omega-3 fish oil

University of Georgia scientists have developed a form of omega-3 fish oil that's easier for people to absorb and leaves no fishy aftertaste.

23 Apr 2004

CellCept linked to reduced cancer incidence

A study presented today at an international transplant meeting showed that heart transplant patients treated with the immunosuppressant CellCeptÒ (mycophenolate mofetil) in standard immunosuppressive regimens had a significantly lower risk of developing cancer compared to those receiving non-CellCept-based treatment regimens.

23 Apr 2004

Hepatitis B vaccination for inmates

rrectional settings provide a unique opportunity to offer hepatitis B vaccination to a substantial number of high-risk adults who are willing to be vaccinated and who would not otherwise have access to the preventive medicine, according to a new Brown University study of inmates within the Rhode Island Department of Corrections.

23 Apr 2004

Schering-Plough submits Japanese application for hepatitis C drug

Schering-Plough Corporation has announced that Schering-Plough K.K., the company's subsidiary in Japan, has submitted a New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) seeking marketing approval for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection for use in combination with REBETOL(R) (ribavirin) Capsules for the treatment of chronic hepatitis C.

22 Apr 2004

Liver News and Research

Despite spending more for health care, Americans do not have the best medical care in the world

A second-generation targetted antibody for potential cancer therapy

New guidelines for using new antiepileptic drugs to treat epilepsy

Embryo testing could produce babies who might aid sick siblings

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Study suggests that the vitamins, such as E, C, and beta carotene, could raise bad form of cholesterol

Study identifies key factor causing low iron and anemia in patients with infections and major inflammatory diseases

Wyeth gets FDA approval for a novel protein device that enhances bone healing

New radiology camera delivers sophisticated technology to Cambridge Medical Center patients

Study of an oral fumarate shows improvement in psoriasis

Shubao slimming capsules contain illegal Fenfluramine and Nitrosofenfluramine

California has set a public health goal for arsenic levels in drinking water

NYU School of Medicine and Bellevue to examine health issues in hispanic population

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Research yields new epilepsy guidelines

First pancreatic islet cell transplant in Alabama

Scientists have developed a better form of omega-3 fish oil

CellCept linked to reduced cancer incidence

Hepatitis B vaccination for inmates

Schering-Plough submits Japanese application for hepatitis C drug

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News